|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Zymergen
gptkb:Dutch_DNA_Biotech
gptkb:FGen
Aldevron (partial assets)
|
|
gptkbp:collaboratesWith
|
gptkb:Bayer
gptkb:Moderna
gptkb:AstraZeneca
gptkb:Bill_&_Melinda_Gates_Foundation
gptkb:Aldevron
gptkb:Corteva
gptkb:Sumitomo_Chemical
gptkb:Synlogic
gptkb:Viking_Global_Investors
|
|
gptkbp:foundedYear
|
2008
|
|
gptkbp:founder
|
gptkb:Tom_Knight
gptkb:Jason_Kelly
gptkb:Austin_Che
gptkb:Barry_Canton
gptkb:Reshma_Shetty
|
|
gptkbp:headquartersLocation
|
gptkb:Boston,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ginkgo Bioworks
|
|
gptkbp:industry
|
gptkb:biotechnology
synthetic biology
|
|
gptkbp:mission
|
to make biology easier to engineer
|
|
gptkbp:notableInvestment
|
gptkb:Bill_Gates
gptkb:Khosla_Ventures
gptkb:Massachusetts_Institute_of_Technology
gptkb:Yuri_Milner
gptkb:GIC_Private_Limited
gptkb:Bill_&_Melinda_Gates_Foundation
gptkb:ARK_Investment_Management
gptkb:Allen_&_Company
gptkb:Baillie_Gifford
gptkb:Cascade_Investment
gptkb:Cathie_Wood
gptkb:DCVC
gptkb:Data_Collective
gptkb:F-Prime_Capital_Partners
gptkb:Felicis_Ventures
gptkb:Fidelity_Management_&_Research_Company
gptkb:First_Round_Capital
gptkb:General_Atlantic
gptkb:Horizons_Ventures
gptkb:OS_Fund
gptkb:Senator_Investment_Group
gptkb:Sozo_Ventures
gptkb:T._Rowe_Price
gptkb:Viking_Global_Investors
gptkb:Y_Combinator
gptkb:iGlobe_Partners
Fidelity
|
|
gptkbp:notableProduct
|
cell programming platform
|
|
gptkbp:notableProject
|
COVID-19 testing
|
|
gptkbp:numberOfEmployees
|
over 900
|
|
gptkbp:publicListingDate
|
September 2021
|
|
gptkbp:publicListingMethod
|
SPAC merger
|
|
gptkbp:stockExchange
|
gptkb:New_York_Stock_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:gene
|
|
gptkbp:valuationAtIPO
|
$15 billion
|
|
gptkbp:website
|
https://www.ginkgobioworks.com/
|
|
gptkbp:bfsParent
|
gptkb:Peter_Thiel
gptkb:Tom_Knight
gptkb:麻省理工學院
|
|
gptkbp:bfsLayer
|
4
|